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Increased levels of inflammatory cytokines in the
female reproductive tract are associated with
altered expression of proteases, mucosal barrier
proteins, and an influx of HIV-susceptible target
cells
Kelly B Arnold1,13, Adam Burgener2,3,4,13, Kenzie Birse2,3, Laura Romas2,3, Laura J Dunphy1,
Kamnoosh Shahabi5, Max Abou2, Garrett R Westmacott6, Stuart McCorrister6, Jessie Kwatampora7,
Billy Nyanga7, Joshua Kimani3,7, Lindi Masson8,9, Lenine J Liebenberg9, Salim S Abdool Karim9,10,
Jo-Ann S Passmore8,9,11, Douglas A Lauffenburger1, Rupert Kaul5,7,12,14 and Lyle R McKinnon5,7,9,14
Elevated inflammatory cytokines (EMCs) at mucosal surfaces have been associated with HIV susceptibility, but the
underlying mechanisms remain unclear. We characterized the soluble mucosal proteome associated with elevated
cytokine expression in the female reproductive tract. A scoring system was devised based on the elevation (upper
quartile) of at least three of seven inflammatory cytokines in cervicovaginal lavage. Using this score, HIV-uninfected
Kenyan women were classified as either having EMC (n¼ 28) or not (n¼68). Of 455 proteins quantified in proteomic
analyses, 53 were associated with EMC (5% false discovery rate threshold). EMCs were associated with proteases, cell
motility, and actin cytoskeletal pathways, whereas protease inhibitor, epidermal cell differentiation, and cornified
envelope pathways were decreased. Multivariate analysis identified an optimal signature of 16 proteins that
distinguished the EMC group with 88% accuracy. Three proteins in this signature were neutrophil-associated proteases
that correlated with many cytokines, especially GM-CSF (granulocyte–macrophage colony-stimulating factor), IL-1b
(interleukin-1b), MIP-3a (macrophage inflammatory protein-3a), IL-17, and IL-8. Gene set enrichment analyses
implicated activated immune cells; we verified experimentally that EMC women had an increased frequency of
endocervical CD4þ Tcells. These data reveal strong linkages between mucosal cytokines, barrier function, proteases,
and immune cell movement, and propose these as potential mechanisms that increase risk of HIV acquisition.
INTRODUCTION
Although the biological process of inflammation is central to
the initiation of an effective host immune response, HIV is able
to turn both inflammation and immune activation to its
advantage.1,2 Immune activation was one of the earliest
observed consequences of HIV infection,3 even before the
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virus was fully characterized. HIV prefers to replicate in activated
CD4þ T cells,4 and T-cell immune activation in some cohorts
was a better predictor of mortality compared with plasma viral
load.5 The early stages of HIV infection are characterized by
inflammation and profound immune dysregulation in the gut
mucosa,6,7 and genital inflammation at this stage also correlates
with an increased plasma viral load.8 Even during treated HIV
infection, residual inflammation markers are associated with
increased AIDS mortality,9 and with persistent gut immune
dysfunction and barrier disruption.10 Taken together, it is clear
that inflammation is a key mediator of HIV pathogenesis.
The role of inflammation in HIV transmission has been
more difficult to ascertain. Non-human primate studies suggest
that mucosal Simian immunodeficiency virus exposure leads to
an inflammatory cascade required for the establishment of
productive viral infection.11 Genital levels of the a-defensins,
antimicrobial peptides that induce proinflammatory cyto-
kine release by T cells,12 were associated with increased
HIV acquisition rates in both women13 and men.14 Genital
coinfections have been associated with mucosal inflammation,
but are not required for inflammation to be present, suggesting
that inflammation owing to multiple causes enhances HIV risk.
The levels of inflammatory cytokines and chemokines, which
signal the presence of infection and recruit activated immune
cells to the mucosa, are frequently used as biomarkers of
inflammation in the female reproductive tract (FRT).15–18 As
such, it might be expected that elevated mucosal cytokines
would be correlated with increased rates of HIV acquisition. In
the CAPRISA002 study, increased levels of proinflammatory
cytokines were associated with increased rates of HIV acqui-
sition.19 These results were subsequently validated in the
CAPRISA004 tenofovir 1% gel trial, where a similar cytokine
profile was a strong predictor of subsequent HIV acquisition.20
In this analysis, a threefold increased risk of HIV infection was
observed in women who had elevated levels of at least three
proinflammatory cytokines (including macrophage inflamma-
tory protein-1a (MIP-1a), interleukin-8 (IL-8), MIP-1b, IL-1b,
IL-1a, and tumor necrosis factor-a (TNF-a)) in cervicovaginal
lavage (CVL).
Despite the strong association of inflammatory cytokines
with HIV acquisition, the cellular and molecular mechanisms
that mediate this risk remain largely unknown. Recent
technological advances in mass spectrometry offer the
promising opportunity to discover new mechanisms linking
inflammatory cytokines and HIV risk in human cohorts, via the
concomitant measurement of hundreds of proteins from small
volume human mucosal samples.21–24 However, collection of
data on this scale can lead to complexities of interpretation, as
deciphering long ‘‘significant’’ protein lists or univariate
analyses can miss important effects on pathways and
perturbations in function categories. This can be mitigated
in part by clustering and pathway analyses tools, which offer the
opportunity to understand study group distinctions based on
groups of biomarkers. Additionally, multivariate classification
and regression techniques enable identification of minimal
protein signatures associated with disease state based on
protein ‘‘patterns’’, or covarying proteins.25 These have been
used previously by our group and others to gain insight into
complex biological processes.26
Here we analyzed the mucosal proteome associated with
elevated levels of cytokines measured in the same specimens
collected ex vivo from high-risk -uninfected women. This
elevated mucosal cytokine pattern, which has been associated
with both higher rates of HIV acquisition and is over-
represented in women with bacterial inflammatory sexually
transmitted infections,27 was associated with profound differ-
ences in mucosal protein expression. Unsupervised hierarchical
clustering of mucosal protein expression levels indicated that
elevated cytokines were associated with visually distinct
proteomes, and pathway analyses indicated perturbed protease
activity, actin filament organization, and epidermal cell
differentiation pathways. Multivariate data-driven analysis
techniques found a unique signature of 16 proteins that best
defined the elevated cytokine group. Three of 16 proteins were
neutrophil-associated proteases, which in turn were signifi-
cantly correlated to multiple inflammatory cytokines, and an
increased frequency of cytobrush-derived cervical CD4þ T
cells. Overall, these data provide a detailed characterization of
mucosal cytokine pathways in the female genital tract, and
propose several potential mechanisms of HIV susceptibility.
RESULTS
Participant characteristics
This study recruited participants from a dedicated female sex
worker clinic in Nairobi, Kenya. We used a scoring system to
classify participants (n¼ 96) having elevated mucosal cyto-
kines on the basis of relative levels of proinflammatory FRT
cytokines measured in CVL to identify extreme phenotypes.
Women who had at least three CVL cytokines (TNF-a, IL-1a,
IL-8, MIP-3a, RANTES (regulated on activation normal T cell
expressed and secreted), IL-1b, and MIP-1b) in the upper
quartile were defined as ‘‘elevated’’; 29% (28/96) of study
participants met this definition, and the rest were considered to
be non-elevated controls. To verify the utility of this definition,
we used unsupervised hierarchical clustering of CVL cytokine
levels (Figure 1). This analysis confirmed that our elevated
cytokine group tended to have increased levels of most of the
cytokines in the multiplex panel, and a large proportion of these
women clustered as having a distinct inflammatory cytokine
phenotype.
We next compared selected demographic, behavioral, and
reproductive variables between participants groups (Table 1).
The only significant difference between groups was douching,
with inflamed women less likely to douche (32% vs. 62%,
P¼ 0.013). Because the substance used to douche may have
important mucosal effects,28 we further compared differences
in douching practice between groups. ‘‘Soap and water’’ and
‘‘water only’’ were the most commonly reported. Although
douching was less common in elevated inflammatory cytokine
(EMC) vs. controls, EMCs were more likely to douche with
soap (55% vs. 32%, P¼ 0.25), whereas EMCs were less likely
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compared with controls to report douching with water only
(44% vs. 53%, P¼ 0.72). It is important to note that this was not
the objective of the study, and we were therefore underpowered
to draw any strong conclusions regarding the mucosal impact
of vaginal douching. No differences in age, marital status, or
education were observed. Women with bacterial vaginosis,
Figure 1 Unsupervised hierarchical clustering of individuals based on female reproductive tract (FRT) cytokines. Elevated inflammatory cytokine
(EMC) (purple) and control (orange) groups were largely segregated using this approach, confirming that our cytokine scoring system identified women
with a distinct cytokine phenotype.
Table 1 Participant characteristics
Variable Elevated mucosal cytokines (% (n/N)) Controls (% (n/N)) P value
Age (median, IQR) 28.5 (25, 31) 28 (25.25, 34) 0.65
Marital status, divorced/widowed/separateda 60.7 (17/28) 54.4 (37/68) 0.65
Highest education¼primary 82.1 (23/28) 82.4 (56/68) 0.35
Injectable contraceptives 21.4 (6/28) 35.3 (24/68) 0.23
Actively cyclinga 85.2 (23/27) 73.1 (49/67) 0.29
Days since LMP if cycling (median, IQR) 10 (7, 20) 13 (9, 24) 0.25
Any STI (proportion) 14.3 (4/28) 7.4 (5/68) 0.44
HSV-2 serostatus 48.1 (13/27) 57.8 (37/64) 0.49
HPV infection 21.4 (6/28) 23.5 (16/68) 1.0
BV 20.8 (5/24) 6.9 (4/54) 0.11
Yeast on Gram stain 12.5 (3/24) 3.4 (2/58) 0.15
Number of clients per week (median, IQR) 8.5 (6, 11.5) 10 (7,14) 0.10
Condom use 71.4 (20/28) 55.9 (38/68) 0.18
Regular partner 32.1 (9/28) 16.2 (11/68) 0.10
Uses condoms with regular partner 78.3 (18/23) 47.1 (23/48) 0.13
Had sexual partners the day before the visit 50 (14/28) 52.9 (36/68) 0.97
Douche 32.1 (9/28) 61.8 (42/68) 0.013
Douche with water onlyb 44.4 (4/9) 53.7 (22/41) 0.721
Douche with water and soapc 55.6 (5/9) 31.7 (13/41) 0.253
Alcohol consumption 71.4 (20/28) 73.5 (50/68) 0.81
FRT, female reproductive tract; IQR, interquartile range; LMP, last menstrual period; STI, sexually transmitted infection.
aRemainder were single.
bDefined as o35 days since LMP.
cOf those who reported douching.
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classical sexually transmitted infections, and/or vaginal yeast
tended to be more inflamed, although the study was under-
powered for this purpose. Similarly, trends were observed for
having a regular sexual partner, the number of partners, and
condom use, but none reached statistical significance (PZ0.1).
The prevalence of herpes simplex virus and human papillo-
mavirus infections at the study visit was comparable between
groups. No differences in reproductive variables were evident.
Mucosal proteome associated with elevated female genital
tract cytokines
We used proteomic analysis of CVL fluid to further examine
differences between women. From a total of 455 human and
microbial quantified factors in the FRT proteome, 109/455
(24.0%) were associated with elevated cytokines at the Po0.05
level (Figure 2). Following multiple test correction based on a
set false discovery rate (q-value) of 5% (Po0.0055), 53 factors
remained associated with elevated mucosal cytokines (Figure 2
and Supplementary Table 1 online). The top 9 differentially
abundant factors (significant after Sidak–Bonferroni correc-
tion, Po0.000095) were all human, and included overabundant
factors filamin-A (FLNA; þ 2.3-fold change), neutrophil
collagenase (MMP8; þ 2.6-fold change), matrix metallopro-
teinase-9 (MMP9; þ 3.1-fold change), coronin-1 A (COR1A;
þ 2.6-fold change), fibrinogen b-chain (FGB; þ 2.37-fold
change), plastin-2 (LCP1; þ 2.7 fold change); and under-
abundant factors antileukoproteinase (SLPI;  3.6-fold
change), serine protease inhibitors Kazal-type 7 (SPINK7;
 4.4-fold change), and Kazal-type 5 (SPINK5;  2.10-fold
change). Intriguingly, two of the top proteins positively
associated with elevated cytokines were neutrophil proteases
(MMP9 and MMP8), whereas three proteins most negatively
associated with elevated cytokines were antiproteases (SPINK5,
SPINK7, and SLPI). Other proteins associated with elevated
cytokines were cytoskeletal and clotting elements (FLNA,
COR1A, and FGB), suggestive of tissue degradation and/or
remodeling pathways.
To better understand combinations of proteins associated
with elevated mucosal cytokines, we separated the 53
significantly different protein factors into those that were
increased (60%) or decreased (40%) in elevated cytokine
participant group; and used hierarchical clustering within each
of these groups to determine patterns that differentiated study
groups. Differentially abundant proteins for both increased
(Figure 3a) and decreased (Figure 3b) factors clearly discrimi-
nated participant groups. To further explore the functional
implications of these differences, we used the Database
for Annotation, Visualization and Integrated Discovery
(DAVID). This analysis found overabundant proteins in the
elevated cytokine group to be significantly associated with
protease activity, cell motility, cell activation, calcium ion-
binding processes, and actin filament organization and binding
(Figure 3a). Several of these are critical for leukocyte migration
(such as ELANE, CORO1A, ITGB2, and MYH9). Conversely,
decreased protein factors in the elevated cytokine group were
significantly associated with antiprotease activity, epithelial
differentiation, and keratinization, suggestive of impaired
epithelial barrier integrity (Figure 3b). Interestingly, several
of these factors were specific components of the cornified
envelope, a layer of highly crosslinked insoluble proteins
important for an effective physical barrier of the epidermis
(SPR1A, SPR1B, SPRR3, INV, CSTA, SPINK5, FLG).29
Multivariate model associates elevated cytokines with
signatures of protease expression and cytoskeletal
alterations
We next wanted to identify the minimum set of proteins that
best differentiated participants with elevated cytokines from
controls based on covariance, or relationships between
proteins. To identify the minimum multivariate protein profile
of elevated mucosal cytokines, we used the LASSO (Least
Absolute Shrinkage and Selection Operator) method for
regression and shrinkage and partial least-squares discriminant
analysis (PLSDA).25,30 A profile of 16 proteins were best able to
classify the women with elevated cytokines from controls. A
PLSDA model of the 16 selected proteins provided excellent
classification of study groups, with 88% calibration accuracy
and 83% crossvalidation accuracy (Figure 4a). Latent variable 1
(LV1) was able to differentiate most participants with elevated
cytokines (positive scores on LV1) from controls (negative
scores on LV1; Figure 4b). Fifteen of the 16 identified markers
were positively loaded on LV1, indicating that they were
positively associated with elevated cytokines, whereas only
one (cornulin) was negatively loaded on LV1, indicating that it
was negatively associated with elevated cytokines. Interestingly,
of these 16 biomarkers, 3 were proteases associated with
neutrophils (MMP8, MMP9, and LYSC (lysozyme C)), whereas
Figure 2 Volcano plot illustrating fold-change (FC) (x axis) and statistical
significance distribution (y axis) of the proteomic data set. Data points in
orange indicate proteins defined to be significantly differentially expressed
based upon a set false discovery rate (q-value) of 5% (Po0.0055).
Proteins in blue denote those that reached statistical significance using
using the Sidak–Bonferroni method, with an aof 5% (Po0.000095). These
data indicate a wide distribution of both upregulated and downregulated
proteins in mucosa in relation to elevated cytokines.
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Figure 3 Heat map and functional analysis of differentially abundant proteins (qo0.05) from cervicovaginal lavage samples between elevated
inflammatory cytokine (EMC) and controls. Hierarchical clustering of proteins was generated by unsupervised average linkage using Pearson’s
correlation as the distance metric. The abundance of each protein is shown in color (red color denotes overabundant proteins, yellow unchanged, blue are
underabundant compared to the mean) (color bar scale is beneath the figure). (a) Overabundant abundant proteins in inflamed individuals and (b)
underabundant proteins in EMC individuals. The highest scoring and significantly associated (Po0.05) biological processes, molecular functions, and
cellular components as identified by Database for Annotation, Visualization and Integrated Discovery (DAVID) gene ontology analysis with these proteins
are shown below each heatmap. Not all associated functions are shown to reduce vertical sizing. Upregulated functions in the elevated cytokine group
included mostly cell motility/activation and protease activity, whereas downregulated functions included antiprotease activity and epithelial differentiation/
keratinization factors. LASSO (Least Absolute Shrinkage and Selection Operator) model proteins are indicated in red and their corresponding functional
categories (denoted by asterisk), all belonging to the upregulated protein group as in a. Bar = fold increase, EMC/control.
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most others were localized to the cell membrane, actin
cytoskeleton, or extracellular matrix (CORO1A, FLNA,
LCP1, TLN1, TPM4, FIBB, FIBG; Supplementary Table 1).
As proteases and cytoskeletal proteins were all positively loaded
on LV1, this suggests that these classes of proteins are together
upregulated in conjunction with mucosal cytokine levels,
potentially as part of the same biological process. We confirmed
that our identified signature for classifying study groups was
optimal by generating 1,000 additional PLSDA models, each
with 16 different combinations of proteins selected from the
remaining (non-LASSO) 439 measured proteins. This analysis
suggested that our LASSO-selected signature was significantly
better than random models for differentiating our study groups
(Po0.01), as both calibration accuracy and crossvalidation
accuracy were 99.9th percentile rank compared with other
models (Supplementary Figure 1). The fact that covariance of
features were able to separate individuals based on having an
elevated cytokine score suggests that relationships between the
proteins in the identified signature may be of biological interest.
Elevated mucosal cytokine score was associated with gene
sets from stimulated neutrophils and other resident
immune cells in mucosa
To further understand potential cellular relationships with
elevated mucosal cytokines, we used the gene set enrichment
analysis toolset in an attempt to identify phenotypic associa-
tions with the inflamed proteomic data set.31 Our mucosal
proteomic data was compared with independently generated
data sets of various immune cell expression patterns. Inter-
estingly, the top four gene sets included three positively
associated and one negatively associated with having an
elevated mucosal cytokine score. Interestingly, the top scoring
gene set was that from stimulated neutrophils (11 proteins:
normalized enrichment score¼ 2.10, Po0.0001; Figure 5a).
The next most enriched gene sets included stimulated CD8þ
T cells (16 proteins: normalized enrichment score¼ 2.00,
Po0.0001; Figure 5b), pathogen-stimulated dendritic cells
(11 proteins: normalized enrichment score¼ 1.96, Po0.0001;
Figure 5c), and influenza-stimluated dendritic cells (30
proteins: ES¼ 1.91, Po0.0001; Figure 5d; full list in
Supplementary Table 2). This influenza-stimulated DC
signature could likely reflect converging downstream,
secreted products that are result of Toll-like receptor or
other pattern recognition of genitally relevant RNA viruses (but
not necessarily influenza). The gene set that included the most
LASSO identified factors was bacterial-stimulated peripheral
blood mononuclear cells (MMP9, MMP8, LYSC, S100A9),
consistent with findings suggesting bacterial infections are
associated with elevated levels of many of the same cytokines in
our panel.27 These data suggest that increased activity of several
immune cell subsets was associated with elevated FRT
cytokines, and that this profile is consistent with increased
microbial stimulation and/or responses.
An elevated mucosal cytokine score was associated with
increased numbers of cervical CD4þ T cells
Although several levels of analysis suggested a relationship
between elevated mucosal cytokines and increased frequency of
immune cells, we wanted to validate this experimentally. While
tissue data was not available at the time of this study, and
neutrophils are technically challenging to stain in frozen
samples, we were able to compare the absolute recovery of
CD4þ T cells—the ideal target cell of HIV—in matched
cervical cytobrush samples taken at the same study visit. Eleven
(of 14) positive associations were observed between the
cytokine level and the number of CD4þ T cells derived from
cervical cytobrush sampling (Supplementary Table 3). Six
of these associations were significant at Po0.01 (Pearson’s
correlation), before adjusting for multiple test corrections.
Similar results were obtained comparing the frequency of
CD4þ T cells in women with cytokine concentrations in the
upper quartile for a given cytokine, vs. the remainder of
participants. Being in the upper quartile for MIP-3a was the
best predictor of cervical T cells (P¼ 0.000317). To test the
relevance of our elevated mucosal cytokine score, we compared
the frequencies of endocervical CD4þ T cells between study
groups. Grouped as per our elevated cytokine score, EMC
women had higher frequencies of CD4þ T cells compared with
Figure 4 Protein signature associated with elevated mucosal cytokines. (a) LASSO (Least Absolute Shrinkage and Selection Operator) used
covariance to identify a 16-protein signature that best classified elevated (red) and nonelevated (blue) groups, with 88% calibration accuracy and 83%
crossvalidation accuracy. (b) Protein contributions to the identified signature can be visualized in the loadings plot, where positive loading indicates
positive association with elevated cytokines, and negative loadings indicates comparative reduction in the elevated group. Three of 16 proteins in the
identified signature were neutrophil proteases (matrix metalloproteinase 8 (MMP8), matrix metalloproteinase 9 (MMP9), and lysozyme (LYSC)), whereas
others were associated with extracellular matrix (ECM), actin cytoskeleton, or cornified envelope. The LASSO identified signature was more predictive for
study group status than each of 1000 different combinations of 16 other proteins for both calibration error (Po0.01) and crossvalidation (CV) error
(Po0.01) (Supplementary Figure 1). LV1, latent variable 1.
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Figure 5 Immune cell gene sets associated with proteomic signatures of elevated mucosal cytokines. (a–d) This figure illustrates gene set enrichment
plots of top stimulated immune cell types during elevated cytokines. Proteins contributing to the majority of the enrichment score are indicated by red dots
(upregulated) in positively enriched gene sets in elevated cytokine individuals, and blue dots (downregulated) of negatively enriched gene sets in elevated
cytokine individuals, and separated by a vertical dotted line. Corresponding gene sets are shown at the top of each figure. mDC, myeloid dendritic cell;
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Figure 6 Significant increase in CD4þ T cells in endocervix of individuals with elevated mucosal cytokines. (a) Cytobrush measurements indicated a
significant 2-fold increased in CD4þ T cells in female reproductive tract specimens of matched individuals in which three of seven inflammatory cytokines
were elevated. P value determined using Mann—Whitney test. (b) Number of endocervical CD4þ T cells stratified by the number of elevated mucosal
cytokines. ECM, extracellular matrix.
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controls (median 896 vs. 345 cells, Po0.001; Figure 6a). We
also compared mucosal CD4þ T-cell frequencies with respect
to increasing numbers of mucosal cytokines in the upper
quartile; here, a marked increase in HIV target cells is evident in
all participant groups with three or more elevated cytokines
compared with women with two or fewer mucosal cytokines in
the upper quartile (Pearson’s r2¼ 0.34, Po0.001; Figure 6b).
These data confirm that elevated cytokines are associated with
an increase in mucosal HIV target cells.
Protease levels are positively associated with cervical
CD4þ T-cell numbers, and inflammatory cytokine
expression
Although the unsupervised clustering suggests the colinearity
of multiple cytokines elevated in the same samples, we wanted
to know the individual cytokine contributions driving our main
associations with neutrophil-associated proteases and epithelial
ECM proteins. In particular, we sought to determine which of
the inflammatory cytokines drive neutrophil activity, especially
neutrophil proteases (MMP8, MMP9, and LYSC), which we
hypothesize drove the signature of the elevated cytokine group.
Expression of many inflammatory cytokines correlated posi-
tively with expression of MMP8, MMP9, and LYSC (Po0.01
with adjustments for multiple comparisons; Table 2). Of all
cytokines, IL-1b, MIP-3a, and IL-8 displayed the strongest
correlation values, and correlated with all three proteases (all
Po0.01 after correction for multiple comparisons). There were
also significant correlations between these three neutrophil-
associated proteins and cervical CD4þ T-cell numbers
(Table 2).
DISCUSSION
Evidence from prospective human cohorts and nonhuman
primate models suggest that inflammation may be central to the
transmission of HIV and Simian immunodeficiency virus, but
the precise mechanism(s) underpinning this association
remain unclear. In this work, we used mass spectrometry
measurements and various analytical methods to identify
specific protein signatures most associated with inflammatory
cytokines in cervicovaginal lavage samples. Interestingly, out of
455 proteins measured, we found that proteins involved in
protease activity and epithelial barrier structures were the
defining signature of women with elevated inflammatory
cytokines. This was the main result from several different
types of systems-level analysis, and presents a potential new
mechanism inflammation-mediated HIV susceptibility.
In this work, the use of multiple system-level analytical
techniques allowed us to establish that the genital proteomes of
women with elevated cytokines were clearly distinguishable
from controls. In standard univariate analysis, 410% of
quantified proteins differed significantly between groups at the
5% false discovery rate level, and hierarchical clustering
revealed visually distinct proteomes. Pathways analysis indi-
cated several pathways were either up- (protease expression and
cytoskeletal elements) or down- (antiprotease expression)
regulated. LASSO and PLSDA allowed for identification of the
minimum signature of proteins that differentiated EMC and
control groups, and revealed a profile of 16 that differentiated
the study groups with 88% accuracy, with more than 50% of the
variance in the sample explained by this categorization.The
advantage of these multivariate analysis techniques is that they
enable identification of a key relationships between proteins
that best separate study groups. Application of techniques such
as this could provide significant insight into the mucosal
immune environment that facilitates increased rates of HIV
acquisition in prospective cohort studies of high-risk indivi-
duals. Further knowledge of the protein milieu that corres-
ponds to elevated cytokines has broader relevance for under-
standing host defense in this immune compartment.
In identifying critical differences in the proteomes of women
with EMC, our system-level analysis also generated new
biological insight into processes most altered by inflammation.
One key finding of our analysis was that that protein
biomarkers of tissue remodeling and mucosal barrier integrity
were strongly impacted by elevated cytokines, as was evident in
all types of analyses that we used. Multiple proteins that regulate
actin cytoskeleton organization (LCP1, TLN1, FLNA, COR1A,
TPM4), several of which bind integrins and are concentrated at
cell–cell contacts,32 were associated with elevated cytokines.
Also present in the signature were ECM components
(fibrinogen b- and g-chain) that regulate cell adhesion and
migration.33 Previous work in mice indicated that inflamma-
tion induced ECM remodeling in dermal tissue, and this
remodeling significantly altered immune cell trafficking.34
Table 2 R values for Spearman’s rank correlations of
proteases, cytokines, and CD4þ T-cell numbers
LYSC MMP9 MMP8
GM-CSF 0.39* 0.50* 0.42*
IL-1a 0.34 0.47* 0.46*
IL-8 0.42* 0.52* 0.52*
MCP-1 0.34  0.13 0.03
MIG 0.26  0.01 0.11
MIP-3a 0.45* 0.47* 0.50*
RANTES 0.34 0.29 0.47*
IL-10 0.24 0.37* 0.31
IL-17 0.37* 0.41* 0.45*
IL-1b 0.45* 0.75* 0.67*
IL-6 0.30 0.59* 0.49*
IP-10 0.27 0.08 0.05
MIP-1b 0.31 0.36* 0.31
TNF-a 0.15 0.60* 0.42*
No. of CD4þ cells 0.30* 0.48* 0.43*
GM-CSF, granulocyte–macrophage colony-stimulating factor; IL, interleukin; IP-10,
interferon gamma-induced protein 10; LYSC, lysozyme C; MIG, monokine induced
by interferon-g; MIP, macrophage inflammatory protein; MMP, matrix
metalloproteinase; RANTES, regulated on activation normal T cell expressed and
secreted; TNF, tumor necrosis factor.
GM-CSF, IL-8, MIP-3a, IL-17, and IL-1b were all significantly correlated with 3/3
proteases after correction for multiple comparisons. All three proteases were also
correlated with CD4þ T-cell number.
*Significance (Po0.01) after correction for multiple comparisons.
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However, specific cell types upstream of remodeling were not
investigated. In contrast, the only downregulated protein in the
PLSDA model was cornulin, a key marker of late epidermal
differentiation and expressed in lower levels of cornified
envelope.35 Although not an integral part of the cornified
envelope itself, this complements the univariate analysis
showing other factors involved in the cornified envelope or
in epidermal differentiation are downregulated. This layer is
thought to be an important physical and biological barrier for
host defense in the vaginal tract against microbial infections.36
Taken together, these findings suggest a model in which
tissue remodeling occurs at the expense of effective barrier
function. The low per-coital rates of HIV transmission (1 in
1,250 exposures) suggest that the mucosal barrier in most cases
is quite effective in preventing HIV infection, in the absence of
transmission cofactors.37,38 Although inflammation and its
associated cytokines, chemokines, and growth factors are
required to fight infection and promote tissue repair, mucosal
inflammation as a prolonged or inappropriate process could
lead to impaired function of this effective barrier, as is observed
in the HIV infected gut.39,40 This breakdown could provide
HIV with the critical opportunity needed to gain access to the
immune cells that are required to establish productive infection.
The second novel finding of our analysis tied to barrier
function is the upregulation of several neutrophil-associated
proteins. To date, no data to our knowledge have linked
neutrophils and neutrophil-secreted proteins to the function of
the mucosal barrier during HIV infection.41 Intriguingly, 3 of
16 proteins in the identified signature were neutrophil-
associated proteases (lysozyme, neutrophil collagenase, and
MMP9), whereas another (Protein S100-A9) has been linked to
neutrophil chemotaxis and adhesion.42 In addition, neutrophil-
associated gene set signatures were also identified within the
proteomic data set, although these do not preclude the
involvement of other immune cell types. Neutrophils have
been widely reported to accumulate in the FRT during
infections,43,44 but interestingly have also reported to have a
critical role in endometrial degradation and repair during
normal menstruation.45,46 Preliminary data suggest that
neutrophils are the most common cell recovered from
endocervical cytobrush sampling.47 MIP-3a, IL-1b, and IL-8
in particular may be critical cytokines that influence neutrophil
protease expression, as both were significantly correlated to
protease levels. Previous work in cell culture indicates both IL-
1b and MIP-3a induce neutrophil migration, and that IL-1b is a
defining feature of sexually transmitted infections.27
Neutrophils have been associated with T helper type17
cells,48 which in turn are associated with both IL-1b and MIP-
3a. T helper type 17 cells preferentially express CCR6, the
receptor of MIP-3a, and IL-1b is key in driving the T helper
type 17 phenotype.49 Indeed, we also found that IL-17 was also
significantly correlated with protease expression. Recently, our
group showed that Th17 cells are depleted from the cervix of
HIV-infected individuals,50 and their number and function to
be reduced in the gut.10,51 Another group has also recently
shown these to be optimal HIV target cells.52 Furthermore,
MIP-3a is increased in the cervix during early HIV infection,53
and blockade of chemokines including MIP-3a by anti-
inflammatory glycerol monolaurate prevented nonhuman
primates from acquiring Simian immunodeficiency virus
infection.11 However, it is worth noting that as we did not
ascertain the cellular source of these protein factors, future
experiments will be needed confirm that they originated from
neutrophils vs. other immune cells of the mucosa. Unfortu-
nately, the lavage specimens used here are typically insufficient
for detailed cellular work.47 Cytobrush samples from the
endocervix may contain high concentrations of neutrophils,47
however, because the matching cytobrush specimen for the
current study was used to run the CD4þ T-cell panel, no cells
were available for neutrophil quantitation. In addition, as
neutrophils are highly prone to apoptosis, these would best
measured in fresh samples collected as part of a new study.
Despite this limitation, the evidence from the literature and
data presented in our study warrant further evaluation of
neutrophils in the context of HIV susceptibility presented in the
paper, with a study specifically designed to overcome the
technical challenges of study neutrophils ex vivo. It is also
important to note that it could be neutrophil activities ‘‘per
capita’’, rather than overall neutrophil numbers, which
underpin the associations we find with EMC.
One of the fundamental physiological roles of the cytokines
often used to define inflammation is the recruitment of activated
immune cells; in our study, several different system analyses of the
mucosal proteome pointed to an association between elevated
mucosal cytokines and increased immune cell frequency and
activity. We then verified this by showing that women with
elevated cytokines had significant increases in the number of
endocervical CD4þ T cells. In one respect, this finding suggests
that our inflammatory cytokine scoring method corresponds to
inflammation as measured by the frequencies of immune cells.
Although assessments of additional cell types and the location of
cells within the tissue is a focus of ongoing work, the validity of
quantifying CD4þ T cells has particular relevance to HIV
acquisition risk, since these are now well established as the
optimal viral targets at the time of transmission. These data also
confirm previous work suggesting that proinflammatory cytokine
levels were associated with an increase in cervical T cells.54
One of the limitations of our study is the arbitrary use of a
scoring system to determine participants with elevated
cytokines. However, we believe this classification is useful
for several reasons. For one, it placesB30% of participants into
the ‘‘elevated’’ group, which we believe captures the ‘‘most
inflamed’’ individuals; this is supported by unsupervised
clustering as defining participants with upregulation of
multiple cytokines, suggestive of a robust phenotype. Second,
a similar scoring system was associated with HIV as an outcome
in a prospective analysis of the CAPRISA004 study.20 Although
we cannot relate this mechanism to HIV susceptibility directly
in this study, an expansion of this work has been planned.
Third, our elevated cytokine classification captures a subclinical
definition of inflammation that is in line with the common
presentation of classical bacterial sexually transmitted infection
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such as chlamydia and gonorrhea.19 Although inflammatory
sexually transmitted infections only explain one aspect of
stimuli that might lead to increased cytokine levels,55 these
serve as a model for defining a pathogenic mucosal immune
state. Finally, our confirmatory cytobrush data found that three
or more elevated cytokines appeared to be a threshold whereby
the frequencies of HIV target cells markedly increased
(Figure 6b). While the field of inflammation has grown to
considerable complexity in recent years, our analysis using
elevated cytokines to classify high-risk women sheds
considerable light on the possible functions of these
inflammatory cytokines in the female reproductive tract.
In summary, we found a set of mucosal proteins that defined
distinct proteomes associated with elevated mucosal cytokines,
with potential implications for what mechanisms might
underpin the role these cytokines have in HIV risk. One
hypothesis that emerges from our data links the covariance of
neutrophil proteases with the ECM, actin cytoskeleton, and
cornified envelope. In this model, inflammation-associated
neutrophil proteases perturb epithelial cell differentiation, cell–
cell contacts, and ultimately barrier function and integrity
(Supplementary Figure 2). This could originate as a result of
infection or another type of injury to tissue, causing resident
cells such as epithelial, DC, and/or CD8þ T cells to release
inflammatory cytokines.56 This would then lead to immune cell
influx, including neutrophils, which secrete proteases that
would lead to further tissue injury, a decline in barrier function,
and further inflammatory cytokine release. These results
underscore that while elevated cytokines in the FRT are
important for physiological processes such as menstruation,
implantation and pathogen defense,8,57–60 these may be
detrimental in the context of mucosal HIV exposure. A better
understanding of the timing, causes, and consequences of
vaginal inflammation might not only improve our under-
standing of female reproductive health but also help to prevent
HIV acquisition in young women.
METHODS
Study population. All participants (n¼ 96) were HIV-uninfected
female sex workers residing in Nairobi, Kenya accessing a clinic in the
Kariobangi area. All participants gave informed written consent before
participation and the study was approved at Institutional Review
Boards at Kenyatta National Hospital (Kenya) and the University of
Toronto (Canada). At the time of sampling, a questionnaire was
administered capturing a range of demographic, reproductive, and
behavioural variables. Participants were tested for a range of sexually
transmitted infections including human papillomavirus (Aptima),
herpes simplex virus-2 serostatus, HIV serostatus, Neisseria gonor-
rhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Mycoplasma
genitalium, and bacterial vaginosis. All infections were treated as per
Kenyan guidelines.
Flow cytometry. Endocervical cytobrushes were obtained as pre-
viously described by insertion and 3601 rotation of a cytobrush in the
endocervical os.50 Cytobrushes were kept on ice until transport to the
lab within 4 h. Cells were liberated from the brush through a
combination of vortexting and washing, filtered, and cryopreserved for
subsequent batched analysis. Thawed cells were washed two times and
rested for 4 h, followed by staining to characterize CD4þ T-cell
populations. Panels of pretitrated antibodies and live-dead stain were
incubated for 20 min at room temperature. Cells were then washed,
fixed, and acquired on a BD LSR2 flow cytometer (Becton Dickinson,
Franklin Lakes, NJ) configured for 10 colors. All events were collected,
allowing an estimation of cells per cytobrush. For the purposes of this
analysis, a gating strategy was used to define CD4þ T cells as those cells
in the live, singlet, lymphocyte gate that coexpressed CD3 and CD4
(analyzed in FlowJo v.9.7.5).
Cytokine/chemokine measurements. CVLs were screened using the
mesoscale discovery electrochemiluminscent ELISA system, and
compared between participant groups. A panel of 14 markers was
assessed (GM-CSF, IL-1a, IL-8, MCP-1 (monocyte chemotactic
protein-1), MIG (monokine induced by interferon-g), MIP-3a,
RANTES, IL-10, IL-17, IL-1b, IL-6, interferon g-induced protein 10
(IP-10), MIP-1b, TNF-a). CVL was plated at 50 ml per well and run in
duplicate. A standard curve was used to determine the concentration
(pg ml 1). The lower limit of quantitation was determined as the
dilution in which the coefficient of variation exceeded 30%. Any
sample above the range of the standard curve was repeated following
dilution. Samples were run and analyzed by personnel who were
blinded to study status. Data were presented as log10-transformed
values to normalize distributions.
Sample preparation for mass spectrometry analysis. Protein
content of CVL samples was determined by BCA assay (Novagen,
Etobicoke, ON, Canada). Equal protein amounts (100 mg) from each
sample were then individually denatured with urea exchange buffer
(8 M urea (GE HealthCare, Mississauga, ON, Canada), 50 mM HEPES
(Sigma, St Louis, MO), pH 8.0) for 20 min at room temperature placed
into Nanosep filter cartridges (10 kDa). Samples were centrifuged, and
reduced with 25 mM dithiothreitol (Sigma) for 20 min, then alkylated
with 50 mM iodoacetamide (Sigma) for 20 min, followed by washes
with 50 mM HEPES. Trypsin (Promega, Madison, WI) was added
(2 mg/100 mg protein) and incubated at 37 1C overnight in the car-
tridge. Peptides were eluted off the filter with 50 mM HEPES, and were
dried via vacuum centrifugation. Reversed-phase liquid chromato-
graphy (high pH RP, Agilent 1200 series microflow pump, Water
XBridge column) was used for desalting and detergent removal of
peptides using a step-function gradient as described previously.21
Eluted fractions were dried via vacuum centrifugation and kept at
 80 1C until analyzed by mass spectrometry.
Mass spectrometry analysis. CVL peptide samples were analyzed by
label-free tandem mass spectrometry as described previously.21 Briefly,
peptide samples were injected into a nanoflow LC system (Easy nLC;
Thermo Fisher, Waltham, MA) connected inline to a LTQ Orbitrap
Velos (Thermo Fisher) mass spectrometer. Database searching was
carried out with Mascot v2.4.0 (Matrix Science, Boston, MA) against
UniProtKB/SwissProt (2013-02) Human- and Bacteria-only data-
bases. Label-free protein abundance levels based on MS peak
intensities were calculated using Progenesis LC-MS software (v4.0
Nonlinear Dynamics, Durham, NC). Complete details of liquid
chromatography and mass spectrometry instrument settings are as
described previously.21
Proteomic data analysis. Relative levels of protein abundance were
calculated by dividing by average intensity across all samples, followed
by log transformation (base 2). Statistical analysis between inflamed
and non-inflamed groups was performed by Student’s t-test (para-
metric). Only proteins that had an average covariance of o25% (455
proteins), as determined through measurements of standard reference
sample run at 10 sample intervals (total 11 times), were used in
downstream analysis to exclude proteins with higher technical
measurement variability. Graphical representation of proteomic data
was constructed using GraphPad Prism software (v6.0c, San Diego,
CA). Differentially abundant proteins were those that passed a set false
discovery rate threshold of 5% (Po0.0055). Clustering of differentially
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abundant proteins was generated by unsupervised average linkage
hierarchical clustering using Pearson’s correlation coefficient as the
distance metric. The two major branches identified in the heatmap
(overabundant/underabundant) were analyzed using the DAVID
Bioinformatics Resource (6.7).61,62
Biological function analysis. Biological/molecular functions and
cellular component annotations were based on gene ontologies. A
modified Fisher’s exact P-value is calculated to determine the
probability that the association between each protein in the data set
and functional pathway is random. Functional categories with P-
values o0.05 and at least three proteins selected were considered to be
associated with each branch in the cluster analysis.
Gene set enrichment analysis. We compared protein expression
profiles to immune-related collections of gene sets from the
Immunological Signatures database (C7.all.v4.0). A ranked list was
generated from normalized protein abundance levels across all
individuals. Gene set enrichment analysis (version 2.1.0) was run using
default parameters. Gene sets with the top 10 most intense (þ / )
normalized enrichment score were significant at a¼ 0.05 (false
discovery rate o0.25 as per gene set enrichment analysis recom-
mendation) and had 410 proteins associated were said to be enriched
in the inflammation phenotype.
Statistical analysis and modeling. We compared participant groups
in Table 1 using w2 and Mann–Whitney U-test for categorical and
continuous variables, respectively. Initial analysis of proteomics data
was carried out by a combination of independent sample T-tests and
fold change, with two different multiple test corrections (listed in the
text). Correlations between cytokines and proteases were assessed
using Spearman’s correlation coefficients, with Bonferonni adjust-
ments for multiple comparisons. In the validation cohort, we com-
pared protease expression between groups using a one-tailed Mann–
Whitney test.
Multivariate analysis. The minimum set of proteins necessary to
distinguish study groups was determined with the LASSO method for
regression shrinkage and selection, implemented using Matlab
software (Mathworks, Natick, MA). K-fold crossvalidation determined
the optimum value of the tuning parameter (‘‘s’’), such that the
resulting model had the lowest possible mean squared error for
prediction and associated features were chosen as the minimum set of
biomarkers. PLSDA assessed prediction ability of LASSO-selected
biomarkers for classifying participant groups. Data were normalized
with mean centering and variance scaling, and crossvalidation was
performed by iteratively excluding random subsets (in groups of 9–10
data points) during model calibration, and then using excluded data
samples to test model predictions.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper
at http://www.nature.com/mi
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